These results indicate that CD8+ T cells from GCB-LMP1/2A mice exhibit more potent proliferative and cytotoxic responses to T-ALL tumor cell lines, likely due to prior activation by BLMP1/2A cells in vivo, enhancing their antitumor immune function. This evidence concerns the gene CD8A and neoplasm.